PWR
54
-3
PSX
29
4
TGT
54
-3
BWA
38
-6
ISRG
67
5
BK
63
2
NOC
45
2
FSLR
57
-4
XRAY
28
3
EBAY
62
12
DTE
63
5
EXPD
23
2
PHM
43
6
GIS
34
2
UNH
45
4
TXN
38
3
ADP
66
4
UNP
38
2
MLM
32
5
O
20
-8
PWR
54
-3
PSX
29
4
TGT
54
-3
BWA
38
-6
ISRG
67
5
BK
63
2
NOC
45
2
FSLR
57
-4
XRAY
28
3
EBAY
62
12
DTE
63
5
EXPD
23
2
PHM
43
6
GIS
34
2
UNH
45
4
TXN
38
3
ADP
66
4
UNP
38
2
MLM
32
5
O
20
-8
Financhill
Back

Invesco FTSE RAFI U.S. Index ETF II USD Vs. Janux Therapeutics Industry Stock Comparison

Sell
28

PXS.U.TO
Invesco FTSE RAFI U.S. Index ETF II USD

Last Price:
$35.13
Seasonality Move:
1.72%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Sell
28
Invesco FTSE RAFI U.S. Index ETF II USD (PXS.U.TO) is a Sell

Is Invesco FTSE RAFI U.S. Index ETF II USD a Buy, Sell or Hold?

  • The current Invesco FTSE RAFI U.S. Index ETF II USD [PXS.U.TO] share price is $35.13. The Score for PXS.U.TO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • PXS.U.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PXS.U.TO Stock Price Chart

What is Invesco FTSE RAFI U.S. Index ETF II USD's stock price today?

  • The Invesco FTSE RAFI U.S. Index ETF II USD share price today is $35.13
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PXS.U.TO is experiencing slight buying pressure.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

PXS.U.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 28.18 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.13 - 36.77) Sell
Bollinger Bands (100): (33.6 - 36) Buy

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

PXS.U.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.57 Sell
20-day SMA: 36.12 Sell
50-day SMA: 35.63 Sell
200-day SMA: 33.4 Buy
8-day EMA: 35.49 Sell
20-day EMA: 35.8 Sell
50-day EMA: 35.57 Sell
200-day EMA: 33.6 Buy

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

Invesco FTSE RAFI U.S. Index ETF II USD Earnings Growth & PXS.U.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

Invesco FTSE RAFI U.S. Index ETF II USD Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):